4 New IPOs for the Week of Oct. 20

Francis Gaskins |

ipo for week of oct. 20, ipos this week, new ipos, best ipos, ipos in october 2014

The week of Oct. 20 is scheduled for four IPOs to begin trading in the public markets. All four companies will list on the Nasdaq, set for about $300 million to be raised.

Full IPO calendar HERE  In order of largest IPO first. 

(1) Based in Greenwich, CT, Fifth Street Asset Management (FSAM) scheduled a $200 million on the Nasdaq with a market capitalization of $1.2 billion at a price range midpoint of $25 for Wednesday, Oct. 22, 2014.

FSAM is a leading alternative asset manager with more than $5.6 billion of assets under management.



(2) Based in Waltham, MA, Proteon Therapeutics (PRTO) scheduled a $61 million IPO on Nasdaq with a market capitalization of $183 million at a price range midpoint of $13 for Wednesday, Oct. 22, 2014.

Targeting kidney failure, PRTO initiated the first of two Phase 3 trials for PRT-201 in radiocephalic AVFs, PRTO’s initial indication, in the third quarter of 2014 and expect to initiate the second Phase 3 trial in the first half of 2015.

(3) Based in St. Louis, MO, EndoStim (STIM) scheduled a $35 million IPO on the Nasdaq with a market capitalization of $92 million at a price range midpoint of $11 for the week of October 20,  2014.

STIM is a medical device company focused on the development and commercialization of a novel neurostimulation system for the treatment of severe gastroesophageal reflux disease, or GERD.

(4) Based in  Madison, WI, Anchor BanCorp Wisconsin  (ABCW) scheduled a $10 million IPO on the Nasdaq with a market capitalization of $242 million at a price range midpoint of $26 for the week of October 20, 2014.

ABCW is a bank incorporated as a savings and loan holding company under the laws of the State of Delaware and headquartered in Madison, Wisconsin.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
FSAM Fifth Street Asset Management Inc. 3.95 0.05 1.28 14,465 Trade
PRTO Proteon Therapeutics Inc. 2.30 -0.05 -2.13 23,901 Trade
ABCW Anchor BanCorp Wisconsin Inc (DE) n/a n/a n/a 0 Trade

Comments

Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

iPRO Network, LLC

We provide the platform, tools, and resources to empower individuals and professionals to market desirable goods and services to the public, taking the place of traditional methods of commerce.

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…